News

Novocardia™ CEO Dan Blumenthal Shares His Vision for the Future of Cardiovascular Care with Gist Healthcare Daily

The shift toward more outpatient services presents growth opportunities for cardiology practices
SUBSCRIBE TO
NEWS & INSIGHTS

    Novocardia CEO Dan Blumenthal, MD, MBA, was a featured guest on a recent episode of Gist Healthcare Daily podcast. The podcast features leaders in health policy and business to discuss national trends and advances in medicine and the delivery of healthcare. Gist Healthcare Daily is hosted by Alexandra Olgin, a former healthcare reporter for National Public Radio (NPR).

    According to a report by the consulting firm Bain and Company, the number of cardiology procedures done in ambulatory surgery centers is rapidly growing, and will reach about 33 percent of cardiology procedures in the next few years. Ambulatory surgery centers (ACS) can often offer surgical procedures at rates 35 to 50 percent lower than hospitals.

    The shift to outpatient services presents opportunities for cardiologists, Blumenthal says. To help cardiology practices capitalize on the shift, Novocardia offers cardiology practices assistance and guidance in launching new service lines to promote business growth, and practice management services to improve efficiencies and transition to value- and outcome-based models. Novocardia can also help partner practices with the development of ambulatory surgery centers and outpatient cath labs.

    “We’ve prioritized partnering with independent groups who we think are delivering high quality care, and have good clinical leadership,” Blumenthal told Gist.

    The savings to the government and patients that could result from moving more coronary interventions out of hospitals and into ambulance surgery centers is significant, Olgin notes. Recently, Medicare estimated that moving just 5 percent of coronary intervention procedures from hospital outpatient department settings to ambulatory surgery centers would save Medicare $20 million, and beneficiaries $5 million in out of pocket costs.

    “With those savings, it’s likely commercial payers will follow Medicare’s lead and incentivize more and more cardiac procedures to be done in these outpatient settings,” she says.

    Listen to the podcast

    Novocardia™ Cardiologist Co-Authors
    JAMA Study on Familial Idiopathic Dilated
    Cardiomyopathy

    Dr. Javier Jimenez of My Cardiologist is a researcher with a national consortium studying DCM, a heart muscle disease that’s a leading cause of heart transplantation
    Read
    More

    Novocardia™ Launches Groundbreaking,
    Value-Based Heart Failure Management
    Program to Improve Patient Outcomes
    and Reduce Hospitalizations

    The heart failure program is a new model for cardiology practices in managing heart failure, starting with patients in Northeast Florida
    Read
    More

    Novocardia™ Announces
    Partnership with My Cardiologist

    New Collaboration Aims to Expand Access to High-Quality, High-Value
    Cardiovascular Care in South Florida
    Read
    More

    Medicare Advantage for All

    A Potential Path to Universal Coverage
    Read
    More

    Novocardia™ Recognized as a Rising
    Disruptor by Bernstein in U.S. Health
    Care Services

    Novocardia Joins List of Fast-Growing Private Companies Transforming Health Care Delivery & Outcomes
    Read
    More

    Novocardia™ Named Among
    New York City's Top 101 Health Care
    Companies and Startups of 2021

    Company Recognized for Leading Innovation in Cardiovascular Disease Care with Value-Based Care Delivery Platform
    Read
    More

    Novocardia™ Enters Into
    Partnership with MedAxiom™

    Strategic Alliance Focused on Promoting Common Mission of Transforming Quality, Value, and Outcomes of Cardiovascular Care
    Read
    More

    Novocardia™ Announces
    Key Additions to Leadership Team
    Accelerating Company’s Mission
    & Growth

    Executives Bring Decades of Multifaceted Health Care Experience that Will Enable Cardiologists to More Successfully Navigate Shifts in Cardiovascular Disease Care
    Read
    More

    Novocardia™ Announces
    Partnership with First Coast Heart
    & Vascular Center

    Alliance to Focus on Improving the Quality, Access, and Value
    of Cardiovascular Disease Care in Northeast Florida
    Read
    More

    Novocardia™ Announces
    $53.7 Million Financing Led
    by Deerfield Management

    New Venture to Partner with Cardiologists to Improve the Quality
    and Value of Cardiovascular Care in the United States
    Read
    More
    Contact Us
    200 5th Ave., Suite 400
    Waltham MA 02451-8704
    Get Novocardia news, events, and innovations delivered right to your inbox.